Drug Profile
GSK 1827771
Alternative Names: 1827771Latest Information Update: 18 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Antibodies; Antirheumatics
- Mechanism of Action Interleukin 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 31 Dec 2008 Development discontinued for Rheumatoid arthritis during 2008
- 30 Sep 2007 Phase-I clinical trials in Rheumatoid arthritis in USA (Parenteral)